Literature DB >> 928482

Effects of nomifensine (HOE 984) upon psychomotor activity and intracranial self-stimulation in the rat.

R J Katz, G Baldrighi, B J Carroll.   

Abstract

The effects of nomifensine maleate (HOE 984) were evaluated using two behavioral tasks. The drug produced dose related increases in both psychomotor activity and operant responding for brain stimulation reward. These results may point to possible psychostimulant properties for the drug.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 928482     DOI： 10.1016/0091-3057(77)90144-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN： 0091-3057            Impact factor:   3.533


  5 in total

1.  Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Hiromi Asano; Ryuki Chatani; Sachiko Hayata; Hiroko Yokoyama; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Motohiko Takemura
Journal:  Brain Res       Date:  2011-12-31       Impact factor: 3.252

2.  Self-administration in baboons and the discriminative stimulus effects in rats of bupropion, nomifensine, diclofensine and imipramine.

Authors:  R J Lamb; R R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Effects of dopamine uptake inhibitors on schedule-controlled behavior in the squirrel monkey.

Authors:  J W McKearney
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.

Authors:  R W Fuller; S K Hemrick-Luecke; H D Snoddy
Journal:  J Neural Transm Gen Sect       Date:  1994

5.  Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-07       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.